[Double blind study of the efficacy of mebendazole in minor forms of human toxocariasis]

Autor: Jf, Magnaval, Jp, Charlet, de Larrard B

Publikováno v: Europe PubMed Central

The authors discuss the results of a double-blind, placebo-controlled, randomised study on the efficacy of mebendazole versus placebo in the treatment of human toxocariasis in 45 and 43 patients respectively, who exhibited evocative clinical and biol

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::09adb6683438b3f058cf80bfba782adc
https://pubmed.ncbi.nlm.nih.gov/1412141

Seroprevalence and Potential Risk Factors of Toxocariasis among General Population in Southwest Iran: Implications on the One Health Approach.

Autor: Foroutan M; Research Center for Environmental Contaminants (RCEC), Abadan University of Medical Sciences, Abadan, Iran.; Department of Basic Medical Sciences, Faculty of Medicine, Abadan University of Medical Sciences, Abadan, Iran., Vafae Eslahi A; Medical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran., Soltani S; Department of Basic Medical Sciences, Faculty of Medicine, Abadan University of Medical Sciences, Abadan, Iran., Kamyari N; Department of Public Health, School of Health, Abadan University of Medical Sciences, Abadan, Iran., Moradi-Joo E; Department of Management and Medical Information Sciences, Kerman University of Medical Sciences, Kerman, Iran., Magnaval JF; Department of Medical Parasitology, Faculty of Medicine, Paul Sabatier University, 37 Allees Jules-Guesde, 31000 Toulouse, France., Badri M; Medical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.

Publikováno v: Journal of immunology research [J Immunol Res] 2024 Feb 13; Vol. 2024, pp. 4246781. Date of Electronic Publication: 2024 Feb 13 (Print Publication: 2024).

Parasitic Infections and Biological Therapies Targeting Type 2 Inflammation: A VigiBase Study.

Autor: Lifar P; Department of Respiratory Medicine., Montastruc F; Department of Medical and Clinical Pharmacology, Centre of Pharmacovigilance and Pharmacoepidemiology.; Centre of Clinical Investigation 1436, Team PEPSS 'Pharmacology in Population cohortS and biobankS', Toulouse University Hospital Centre, Toulouse, France; and., Reber LL; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), Inserm U1291, University of Toulouse, CNRS U5282, F-CRIN CRISALIS, Toulouse, France., Magnaval JF; Department of Clinical Parasitology, Faculty of Medicine, and., Guilleminault L; Department of Respiratory Medicine.; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), Inserm U1291, University of Toulouse, CNRS U5282, F-CRIN CRISALIS, Toulouse, France.

Publikováno v: American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2023 May 01; Vol. 207 (9), pp. 1253-1255.

Toxocariasis-associated urinary system diseases: a systematic review of reported cases.

Autor: Ardekani A; School of Medicine, Shiraz University of Medical Sciences, Shiraz 7134814336, Iran.; Student Research Committee, Shiraz University of Medical Sciences, Shiraz 7134814336, Iran., Roshanshad A; Student Research Committee, Shiraz University of Medical Sciences, Shiraz 7134814336, Iran., Hosseini SA; Student Research Committee, Shiraz University of Medical Sciences, Shiraz 7134814336, Iran., Magnaval JF; Department of Medical Parasitology, Faculty of Medicine, University of Toulouse, Toulouse 31000, France., Abdollahi A; Department of Surgery, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran 1949635881, Iran., Rostami A; Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol 4717647745, Iran.

Publikováno v: Transactions of the Royal Society of Tropical Medicine and Hygiene [Trans R Soc Trop Med Hyg] 2022 Jul 06; Vol. 116 (7), pp. 668-672.

Human toxocariasis and atopy.

Autor: Magnaval JF; Service de Parasitologie Médicale, Faculté de Médecine, Université de Toulouse, 31000 Toulouse, France., Fillaux J; Service de Parasitologie et Mycologie, Université de Toulouse, Centre Hospitalier Universitaire de Toulouse, TSA 40031-31059 Toulouse cedex 9, France - PharmaDev, Faculté de Pharmacie, Université de Toulouse, IRD, UPS, 31062 Toulouse cedex 9, France., Cassaing S; Service de Parasitologie et Mycologie, Université de Toulouse, Centre Hospitalier Universitaire de Toulouse, TSA 40031-31059 Toulouse cedex 9, France - PharmaDev, Faculté de Pharmacie, Université de Toulouse, IRD, UPS, 31062 Toulouse cedex 9, France., Valentin A; Service de Parasitologie et Mycologie, Université de Toulouse, Centre Hospitalier Universitaire de Toulouse, TSA 40031-31059 Toulouse cedex 9, France - PharmaDev, Faculté de Pharmacie, Université de Toulouse, IRD, UPS, 31062 Toulouse cedex 9, France., Iriart X; Service de Parasitologie et Mycologie, Université de Toulouse, Centre Hospitalier Universitaire de Toulouse, TSA 40031-31059 Toulouse cedex 9, France - Centre de Physiopathologie Toulouse-Purpan (CPTP), Université de Toulouse, INSERM, CNRS, UPS, TSA 40031-31059 Toulouse cedex 9, France., Berry A; Service de Parasitologie et Mycologie, Université de Toulouse, Centre Hospitalier Universitaire de Toulouse, TSA 40031-31059 Toulouse cedex 9, France - Centre de Physiopathologie Toulouse-Purpan (CPTP), Université de Toulouse, INSERM, CNRS, UPS, TSA 40031-31059 Toulouse cedex 9, France.

Publikováno v: Parasite (Paris, France) [Parasite] 2020; Vol. 27, pp. 32. Date of Electronic Publication: 2020 May 13.